Imu Biosciences
London, GB · Founded 2019 · 79 employees on LinkedIn · 6 known investors
Find your way into Imu Biosciences
IMU Biosciences builds an immune-system analysis platform that measures over 100 million datapoints from a single blood sample across large patient populations, an approach it calls HD Immunology. The company applies this high-resolution immune profiling to uncover immune mechanisms and support precision diagnosis, monitoring, and treatment of disease.
Founders & leadership
Imu Biosciences was founded in 2019 by Thomas Hayday PhD, Adam Laing PhD, Mario Cantero MBA, and Adam Laing.
TH
Thomas Hayday PhDCo-founder & Chief Research Officer
AL
Adam Laing PhDCo-founder & Chief Scientific Officer
MC
Mario Cantero MBACo-founder & Chief Operating Officer
AL
Adam LainginCo-Founder, President & CSO
JB
John Baker PhDChief Executive Officer
Investors · 6
ExpaWest Hollywood · $250K – $3M
.jpeg){kind=logo}
IQ CapitalLondon · $1M – $40M
KfundMadrid · $108K – $10.8M
Molten VenturesLondon · $2.5M – $63M
Also in the syndicate · 2
MeltwindThe British Business Bank
Funding
SEC filings, press & company announcements$53M disclosed across 1 round · 2026
- $53MSeries AJun 2026 · 9 sources
IQ Capital (lead), Molten Ventures (lead), Meltwind, The British Business Bank
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Imu Biosciences do?
- IMU Biosciences builds an immune-system analysis platform that measures over 100 million datapoints from a single blood sample across large patient populations, an approach it calls HD Immunology. The company applies this high-resolution immune profiling to uncover immune mechanisms and support precision diagnosis, monitoring, and treatment of disease.
- Who founded Imu Biosciences?
- Imu Biosciences was founded by Thomas Hayday PhD, Adam Laing PhD, Mario Cantero MBA, Adam Laing in 2019.
- Who are Imu Biosciences's investors?
- Imu Biosciences's investors include Expa, IQ Capital, Kfund, Molten Ventures.
- How much funding has Imu Biosciences raised?
- Imu Biosciences has disclosed $53M raised across 1 round.
- Where is Imu Biosciences headquartered?
- Imu Biosciences is headquartered in London, GB.